Treatment of Meconium Aspiration Syndrome with Estrogens
4 Assignments
0 Petitions
Accused Products
Abstract
One aspect of the present invention relates to the use of an estrogen in the treatment of Meconium Aspiration Syndrome (MAS) in a newborn infant, said treatment comprising administering an effective amount of estrogen to said newborn infant within 7 days after birth. The present treatment offers the advantage that estrogens can be administered using non-invasive modes of administration, e.g. oral or rectal administration. Other aspects of the present invention relate to a suppository for use in newborn infants comprising at least 1 μg of estrogen and to an oral applicator comprising a container holding an aqueous liquid containing micronised estetrol and a metering dispenser for metering the liquid into the oral cavity of a newborn infant.
-
Citations
34 Claims
-
1-15. -15. (canceled)
- 16. A method of treating Meconium Aspiration Syndrome (MAS) in a newborn infant, said method comprising administering an effective amount of estrogen to said newborn infant within 7 days after birth.
-
31. A suppository for use in newborn infants comprising at least 1 μ
- g of estrogen, said suppository further being characterized by a maximum diameter of less than 10 mm, preferably of 4-9 mm, and a weight of less than 0.5 g.
- View Dependent Claims (32, 33)
-
34. An oral applicator comprising a container holding a liquid and a metering dispenser for metering the liquid into the oral cavity of a newborn infant, wherein the liquid is an aqueous liquid containing at least 0.5 mg/ml of micronised estetrol.
Specification